Price: $65.76 | Market Cap: $3.67B | Shares Outstanding: 55.79M
Price: $65.76 | Market Cap: $3.67B | Shares Outstanding: 55.79M
| Detail | Info |
|---|---|
| Tenure | CEO since July 2000 (25+ years), Chairman since Feb 2018 |
| Age | ~62 (born 1964) |
| Education | BA Economics, University of Washington; MBA, Harvard Business School |
| How he got here | Founded the company. This is his baby. |
Career before nLIGHT: - Pacific Coast Feather Company – started in manufacturing/quality management - McKinsey & Company (1993-1998) – consultant, San Francisco and Seattle offices - Aculight (1998-2000) – CEO. Aculight was later sold to Lockheed Martin. This is where Keeney first got into laser technology and met several of his future co-founders.
Founded nLIGHT in June 2000 in Washington state (reincorporated in Delaware, renamed to nLIGHT, Inc. in January 2016). He spun the company out from the Aculight orbit with co-founders Jason Farmer and Mark DeVito.
Track record / Vision: - Built nLIGHT from zero to ~$261M revenue and a $3.67B market cap over 25 years - Successfully pivoted the company from a pure industrial laser play to an A&D-dominant business (A&D now 67% of FY25 revenue, up from 36% in FY22) - Won the crown jewel HELSI contract ($171M) for megawatt-class directed energy lasers - Took the company public in April 2018 at $16/share. Stock now at $65.76 – a 4x+ from IPO - The company has NEVER been GAAP profitable on a sustained basis. 25 years of recurring net losses. This is the single biggest knock on the operating track record. - 2007: Ernst & Young Entrepreneur of the Year (Pacific Northwest) - Founded nConnect, an education non-profit for STEM
Founder-CEO dynamics assessment: Keeney is the prototypical technical founder-CEO who survived multiple industry cycles and successfully repositioned the company. The defense pivot is genuinely impressive – it is not easy to take a commercial laser maker and turn it into a directed energy weapons supplier. He has McKinsey strategy chops plus deep industry knowledge from the Aculight days.
The concern: 25 years without sustained profitability. The story has always been “profitability is around the corner” as the defense revenue scales. FY25 showed improvement (non-GAAP net income of $13.1M) but GAAP is still in the red. The massive SBC load is a significant part of why.
Red flags on Keeney specifically: None of a serious nature. No SEC enforcement actions, no personal lawsuits, no bankruptcies. The 2015 False Claims Act settlement ($420K) was a corporate matter, not personal – and was about SBIR grant eligibility technicalities, not fraud in the work itself.
| Detail | Info |
|---|---|
| Tenure | CFO since March 2022 (~4 years). At nLIGHT since 2020. |
| Age | ~44 |
| Education | BA Economics, Swarthmore College |
| How he got here | Hired externally in 2020 as VP Corp Dev & IR, promoted to CFO |
Career before nLIGHT: - Thomas Weisel Partners – analyst, then associate, then VP (investment banking) - Stifel (15+ years) – Global Co-Head of Electronics and Industrial Technology. Advised public companies on corporate finance and M&A. This is where he first crossed paths with Keeney.
Assessment: Classic investment banker turned CFO. The Stifel background means he knows capital markets, M&A structuring, and public company finance cold. He successfully executed the $201M secondary offering in Feb 2026 and the Feb 2026 equity raise. Replaced Ran Bareket, who retired in March 2022.
| Detail | Info |
|---|---|
| Tenure | COO since 2022 (~4 years) |
| Education | BS & MS Mechanical Engineering, MIT; MBA, MIT Sloan |
| How he got here | Hired externally |
Prior roles: - Celestica – VP Operations, Aerospace and Defense segment - Zodiac Seats – VP/GM - StandardAero – VP/GM - Parker Hannifin – Manufacturing Integration Leader (Clarcor Filtration acquisition) - Axcelis Technologies – Director-level roles in product development, operations management, and Lean Six Sigma
Assessment: Extremely strong A&D operations pedigree. MIT-trained engineer with deep manufacturing experience at defense-adjacent companies. This is exactly who you want running operations as LASR scales up directed energy production.
| Detail | Info |
|---|---|
| Tenure | Long-tenured (exact start date unclear, but has been at nLIGHT for many years) |
| Education | MS Electrical & Ocean Engineering, MIT (1989-1991) |
| How he got here | Internal. Previously at Coherent, Novalux, and Corporation for Laser Optics Research (COLOR) |
Assessment: The technical backbone. Deep semiconductor and fiber laser expertise. Drives the core technology roadmap. His long tenure provides continuity on the technology side.
| Detail | Info |
|---|---|
| Tenure | Co-founded nLIGHT in 2000 |
| Education | BS Physics, UC Santa Barbara; MS & PhD Astrophysics, University of Colorado |
| How he got here | Co-founded the company from Aculight |
Assessment: Holds 10+ patents in semiconductor laser technology. Was previously CTO. Career began at Aculight leading solid-state laser and nonlinear optics programs. His PhD in astrophysics provides deep physics knowledge underpinning the technology. Farmer’s current day-to-day role is less public-facing than it once was.
| Name | Title | Notes |
|---|---|---|
| James Nias | VP, Corporate Controller & CAO | Financial reporting |
| Kerry Hill, CPA | Chief Administrative Officer, VP HR | HR and admin functions |
| John Warren Marchetti, MBA | VP Corporate Development & IR | M&A and investor relations |
| Julie Dimmick, JD | VP, General Counsel & Corporate Secretary | Legal and governance |
| Bill Willson | Managing Director, Fiber Division | Fiber laser business |
| Date | Change | Significance |
|---|---|---|
| June 2025 | Doug Carlisle resigned from board (since 2001) | Replaced by Mark Hartman. Carlisle was a long-tenured VC-connected director. |
| June 2025 | Mark Hartman appointed to board (Class III) | Former Woodward CFO. Strengthens A&D financial expertise on the board. |
| Jan 2026 | Gerald M. Haines appointed to board (Class I) | Defense tech veteran. Former CFO of Mercury Systems. Deepens A&D board bench. |
| Aug 2025 | Special performance equity awards announced | 1.2M shares for CEO, 1.0M for senior leadership. Signals retention focus. |
No C-suite departures in the last 2 years. The leadership team has been stable.
| Insider | Title | Shares Held | Estimated Value (@ $65.76) | Notes |
|---|---|---|---|---|
| Scott Keeney | CEO | 2,229,125 direct + 4,474 indirect | ~$146.9M | Indirect via Keeney Family Revocable Trust. Includes unvested RSUs. |
| Joseph Corso | CFO | ~265,418 | ~$17.5M | Includes unvested RSUs |
| Raymond Link | Director | Post-sale holdings not fully specified | – | Has been selling regularly under 10b5-1 |
CEO ownership context: With ~2.23M shares, Keeney holds roughly 4.0% of shares outstanding (55.79M). At $65.76/share, that is approximately $147M in value. This is meaningful skin in the game. For a founder-CEO who has been at it for 25 years, this is a solid holding – though a significant portion is unvested RSUs, not purchased stock.
The pattern is CLEAR: all selling, zero buying.
| Date | Insider | Type | Shares | Avg Price | Value | Plan |
|---|---|---|---|---|---|---|
| Sep 12, 2025 | Keeney (CEO) | Sale | 15,391 | $28.84 | $443K | 10b5-1 |
| Nov 11, 2025 | Link (Dir) | Sale | 12,560 | $35.33 | $444K | 10b5-1 |
| Nov 21, 2025 | Nias (CAO) | Sale | 1,200 | $30.00 | $36K | – |
| Dec 3-4, 2025 | Keeney (CEO) | Sale | ~24,996 | ~$34-36 | ~$873K | 10b5-1 |
| Mar 5-6, 2026 | Keeney (CEO) | Sale | 55,895 | $58-63 | ~$3.4M | 10b5-1 + tax withholding |
| Mar 9, 2026 | Keeney (CEO) | Sale | 19,096 | $56-61 | ~$1.1M | 10b5-1 |
| Mar 9, 2026 | Corso (CFO) | Sale | 13,038 | ~$60 | ~$780K | – |
| Mar 11-13, 2026 | Link (Dir) | Sale | 25,404 | $62-64 | ~$1.6M | 10b5-1 |
Total insider selling (last 6 months): Over $20M across 23 transactions, with ZERO insider purchases.
90-day net: -$3.0M net value, -3 executives, all sales.
Mitigating factors: - Most sales executed under pre-established 10b5-1 plans (adopted June 12, 2025, December 11, 2025) - Some CEO sales were mandatory “sell-to-cover” for RSU tax withholding - Stock ran from ~$6 to ~$70 in about a year – taking some profits off a 10x move is rational - Keeney still holds 2.2M+ shares – he has not meaningfully reduced his position
Concern level: MODERATE. The absence of any insider buying – even a token purchase – during a period when the stock has gone vertical is notable. Nobody on the inside is putting incremental capital in. That said, the magnitude of selling relative to total holdings is not alarming. Keeney sold ~115K shares while holding 2.2M+ (about 5% of position).
nLIGHT has a classified (staggered) board divided into three classes with three-year terms.
| Director | Class | Independent | Since | Background | Committees | Other Boards |
|---|---|---|---|---|---|---|
| Scott Keeney | – | No (CEO) | 2000 | Founder/CEO (see above) | Chairman | – |
| Bill Gossman | – | Yes | 2016 | Venture Partner, Mohr Davidow Ventures (2009-2018) | Lead Independent Director, Comp Committee Chair | – |
| Raymond Link | – | Yes | 2010 | Former CFO: FEI Company, TriQuint Semiconductor, Sawtek. CPA, Wharton MBA. | Audit Committee Chair, Comp Committee | – |
| Bandel Carano | – | Yes | 2001 | Managing Partner, Oak Investment Partners. BS/MS EE, Stanford. | Comp Committee (since Mar 2025), IT Security Committee | NextNav (board) |
| Geoffrey Moore | – | Yes | 2013 | Author of “Crossing the Chasm.” Chairman Emeritus, The Chasm Group. PhD English Literature, UW. | – | WorkFusion, Phaidra |
| Mark Hartman | III | Yes | Jun 2025 | Former CFO, Woodward Inc (16 years). CPA, Kellogg MBA. | Audit Committee | – |
| Gerald Haines | I | Yes | Jan 2026 | Former CFO, Mercury Systems; CFO, Metabolon; EVP/CFO, Impulse Dynamics. JD Cornell Law, BS Boston University. | Audit Committee | – |
Board composition: 6 independent directors out of 7 total (Keeney is the sole non-independent). The board has expanded and refreshed significantly in 2025-2026 with two new A&D-focused financial experts replacing longer-tenured directors.
Assessment: - Strength: Two new directors (Hartman, Haines) bring deep A&D financial expertise, exactly aligned with the company’s strategic direction. Link brings audit rigor from public company CFO roles. - Strength: Lead Independent Director structure mitigates the CEO/Chairman dual-role concern. - Weakness: Bandel Carano has been on the board since 2001 (25 years). This is LONG for an “independent” director. His Oak Investment Partners connection is from nLIGHT’s VC days. ISS gives the board pillar score of 9 (concerning). - Weakness: Geoffrey Moore is a marketing strategy guru, not a laser or defense expert. His PhD is in English literature. He brings market strategy perspective but limited technical or financial oversight depth. - Notable departure: Doug Carlisle resigned June 2025 after 24 years on the board (since 2001). He was also a VC-era legacy director. The board is gradually refreshing its VC-era membership.
| Component | FY2024 | FY2023 (est.) |
|---|---|---|
| Base Salary | $454,077 | ~$440K |
| Bonus/Cash Incentive | $0 | – |
| Stock Awards | $4,672,500 | – |
| Option Awards | $0 | – |
| Other Compensation | $12,499 | – |
| Total | $5,139,076 | – |
Key comp design features: - 90% of target TDC is equity + variable cash; 10% is base salary. This is heavily equity-weighted, which is good for alignment. - Annual cash incentive metrics: Revenue (25% weight) + Adjusted EBITDA (75% weight). In FY2024, the payout was $0 because both targets were missed (Revenue $198.5M vs. $232.1M target; Adj. EBITDA -$17.2M vs. $7.2M target). This shows the plan has teeth. - Equity split: 50% time-based, 50% performance-based RSUs (PRSUs). PRSUs use Monte Carlo valuation with TSR-based vesting. - Say-on-pay: ~97% approval at the 2024 annual meeting. Shareholders are broadly supportive. - Double-trigger CIC provisions (change-in-control requires both a transaction AND termination). No tax gross-ups. Clawback policy in place. Hedging/pledging prohibited.
In August 2025, the Compensation Committee announced special, one-time performance-based equity awards: - CEO Scott Keeney: Up to 1.2 million shares - Other senior leadership: Up to 1.0 million shares combined - Total: Up to 2.2 million shares (~4% of shares outstanding at the time)
These are price-hurdle PRSUs requiring sustained 60-day VWAP thresholds ($30/$35/$40) for vesting. At the time of announcement, LASR was trading around $15-20, so these thresholds represented 50-100%+ appreciation targets.
Assessment: This is aggressive but structured reasonably. The price hurdles have been blown through (stock now at $65+), so a substantial portion has likely vested or is on track to vest. The 2.2M share potential dilution is significant. But the fact that these are performance-based with real price thresholds – not just time-based freebies – is the right design.
| Year | Revenue (M)|SBC(M) | SBC as % of Revenue | |
|---|---|---|---|
| FY2021 | $270.2 | $37.7 | 14.0% |
| FY2022 | $242.1 | $26.8 | 11.1% |
| FY2023 | $209.9 | $25.8 | 12.3% |
| FY2024 | $198.5 | $25.0 | 12.6% |
| FY2025 | $261.3 | $33.4 | 12.8% |
SBC is consistently running 11-14% of revenue. For a company that has never been sustainably GAAP profitable, this is a massive drag. The company earns non-GAAP profits only by excluding SBC – but SBC is real dilution. Shareholders are funding this through share count growth:
| Year | Basic Shares (M) | Dilution from Prior Year |
|---|---|---|
| IPO (2018) | 33.0 | – |
| FY2021 | 42.0 | – |
| FY2022 | 44.0 | +4.8% |
| FY2023 | 46.0 | +4.5% |
| FY2024 | 48.0 | +4.3% |
| FY2025 | 50.0 | +4.2% |
| Current | 55.79 | +11.6% (includes Feb 2026 offering) |
From IPO to now, the share count has increased from 33M to 55.8M – a 69% increase in 8 years. That is a LOT of dilution. The Feb 2026 offering alone added 4.57M shares (nearly 10% dilution in a single event).
| Category | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Cost of revenues | $2,438 | $2,406 | $2,677 |
| R&D | $7,505 | $9,866 | $11,675 |
| SG&A | $15,018 | $13,560 | $12,405 |
| Total | $24,961 | $25,832 | $26,757 |
Note: These are the 10-K reported figures. The cash flow statement figures ($33.4M for FY2025) may include additional SBC items. The SG&A line – which includes executive comp – is the largest and fastest-growing component.
| Year | Target | Price | Rationale | Outcome |
|---|---|---|---|---|
| 2019 | Nutronics, Inc. | $17.5M cash + $15.8M RSUs | Coherently combined lasers and beam control for directed energy. 32 employees, Longmont, CO. Founded 1995. | HOME RUN. This acquisition was the foundation of nLIGHT’s directed energy capabilities. Led directly to the HELSI contracts ($171M+) and the DE M-SHORAD work ($34.5M). The Longmont facility is now being expanded to 50K+ sq ft. |
| ~2020 | OPI Photonics (Italy) | Undisclosed | Component and packaging. Torino, Italy. Pre-existing partnership. | Vertical integration play. Seems to have integrated smoothly. Low profile. |
| Various | Several smaller/earlier acquisitions | – | Pre-IPO technology tucks | Supported vertical integration strategy |
M&A assessment: The Nutronics deal is the single most important capital allocation decision in the company’s history. For ~$33M total consideration, they acquired the technology that powers what is now a $3.67B market cap defense technology company. That is exceptional deal-making, likely driven by Keeney’s deep technical knowledge of what coherent beam combining could become.
| Event | Shares Issued | Proceeds | Dilution Impact |
|---|---|---|---|
| IPO (Apr 2018) | 5.4M | $86.4M (at $16) | Base: 33M shares |
| Feb 2026 Offering | 4.57M | $201M (at $44) | ~9.2% dilution |
| Ongoing SBC | ~2-4M/year | – | ~4-5% annual dilution |
The Feb 2026 offering is the biggest equity event since the IPO. The $201M raised is earmarked for manufacturing expansion and working capital – which makes sense given the HELSI ramp. But shareholders ate nearly 10% dilution in a single event while the stock was at $44, well below the $65+ level where insiders were selling weeks later.
| Year | Capex ($M) | Key Investments |
|---|---|---|
| FY2021 | $19.3 | Directed energy capacity, manufacturing |
| FY2022 | $21.4 | Continued DE buildout |
| FY2023 | $5.3 | Pulled back during downturn |
| FY2024 | $7.9 | Selective investment |
| FY2025 | $9.0 | New Longmont facility, Camas upgrades |
Capex has been conservative relative to revenue, running 3-8% of sales. The new Longmont facility (funded by the Feb 2026 offering) represents a step-up in capacity investment tied to HELSI production scaling.
| Year | R&D ($M) | R&D as % of Revenue |
|---|---|---|
| FY2021 | $54.8 | 20.3% |
| FY2022 | $53.8 | 22.2% |
| FY2023 | $46.2 | 22.0% |
| FY2024 | $45.1 | 22.7% |
| FY2025 | $48.0 | 18.4% |
R&D spending is consistently 18-23% of revenue. This is appropriate for a technology-driven business, though it is another contributor to the persistent GAAP losses. The key R&D outcomes have been exceptional: - 300kW-class laser demonstration (exceeded HELSI Phase 1 objectives) - 450+ patent portfolio - Programmable fiber laser technology - Coherent beam combining (CBC) architecture
nLIGHT has a FULL SUITE of anti-takeover measures:
Assessment: This is fortress-level anti-takeover protection. The combination of a classified board, blank check preferred, no cumulative voting, and supermajority amendment requirements makes a hostile takeover virtually impossible. For a company controlled by a founder-CEO with 4% ownership, these provisions effectively entrench management. The ISS Governance QualityScore is 8 (out of 10, where 10 is worst), with the Board pillar at 9 – confirming poor governance structure by institutional standards.
Based on available filings and search results, no disclosed related-party transactions have been identified. The Audit Committee has formal oversight of related-party transactions and conflicts. This is a clean area.
No evidence of: - Revenue circularity with insider entities - Shell entities controlled by insiders - Asset transfers between related entities - Registered agent overlaps suggesting hidden connections
No activist campaigns identified against nLIGHT.
No shareholder proposals have been identified in recent proxy filings. With the anti-takeover provisions in place, shareholder activism is structurally difficult.
2015 False Claims Act Settlement ($420,000) - nLight Photonics agreed to pay $420K to resolve allegations of violating the federal False Claims Act - Period: 2004-2013 - Allegation: The company received SBIR (Small Business Innovation Research) grants worth $15M+ from Army, Navy, Air Force, NASA, and DOE while not meeting SBIR eligibility requirements. Multiple VC firms owned >51% of nLight, making it ineligible for the small business program. - Discovery: A DOE contracting officer noticed the issue when overseeing both an nLight grant and a grant to a company nLight had acquired. - Resolution: Settlement without admission of liability. The government stated there was “no indication that nLight did not adequately perform the work required.” - Assessment: This is a technicality-level issue, not a fraud issue. The company did the work; the question was whether its VC-backed ownership structure disqualified it from the small business program. The $420K settlement on $15M+ in grants is trivial. The fact that the company itself flagged the issue to a DOE officer suggests transparency, not concealment.
Item 3. Legal Proceedings (10-K): “For a description of our material pending legal proceedings, see Note 12, Commitments and Contingencies.” No major litigation highlighted. The company notes standard risks of IP litigation in the laser industry.
None found. No SEC enforcement actions, no securities fraud lawsuits, no restatements, no material weaknesses in internal controls. The 10-K confirms: - Clean KPMG audit opinion (Portland, Oregon) - Effective internal controls over financial reporting - No changes in or disagreements with accountants - No error corrections requiring restatement - No compensation clawback recovery required
| Pillar | Score (1-10, 10=worst) |
|---|---|
| Overall | 8 |
| Audit | 6 |
| Board | 9 |
| Shareholder Rights | 8 |
| Compensation | 7 |
The Board and Shareholder Rights scores are poor, consistent with the anti-takeover provisions and classified board structure discussed above.
Management quality: B+. Keeney is the real deal as a technical founder-CEO – the defense pivot and Nutronics acquisition demonstrate genuine strategic vision. The team around him is strong and getting stronger. But the governance structure is below-average, the SBC burden is excessive, and the all-selling-no-buying insider pattern warrants monitoring. The absence of sustained GAAP profitability after 25 years means shareholders are betting on the future, not paying for demonstrated earnings power.
The biggest question for investors: Is the SBC load the price you pay for building a directed energy franchise from scratch, or is it chronic value transfer from shareholders to insiders? The answer probably depends on whether HELSI and defense revenue can scale fast enough to make the SBC percentage shrink relative to a much larger revenue base. If LASR gets to $500M+ revenue with current SBC levels, the math works. If growth stalls, shareholders have been diluted for nothing.
Sources: - nLIGHT 10-K (FY2024) - Scott Keeney - Wikipedia - nLIGHT CEO sells 55,895 shares - Form 4 - nLIGHT director sells shares - Form 4 - nLIGHT CEO gets 1.2M share award - Mark Hartman board appointment - Gerald Haines board appointment - nLIGHT $201M offering - Nutronics acquisition - HELSI contract expansion to $171M - nLIGHT False Claims Act settlement - nLIGHT CFO transition - StockAnalysis - LASR financials - nLIGHT Company Profile - nLIGHT Insider Selling - Daily Political